KRAS and breast carcinoma: Some types of cancer, including breast cancer and bladder cancer, showed higher frequency of druggable targets in both cohorts Similarly, some gene alterations, including KRAS and PIK3CA mutations, were shared among different ethnicities, while some alterations, including EGFR mutation (enriched in Chinese NSCLC patients) were variably represented.